White Papers
Optimizing Oncology Clinical Development Programs Via Risk-Based Quality Management (RBQM)
White Paper There are currently more than 700 oncology drugs in later stages of development (Phase II or higher), representing […]
March 31, 2023
Optimizing Oncology Trials via Remote Monitoring
White Paper Within the oncology drug development pipeline, which has increased by over 60% in the past decade1, it is […]
March 31, 2023
Critical Considerations for Rare & Orphan Disease Trial Planning
A Question-First Approach to Operationalizing Rare Disease Studies This Atlantic Research Group rare disease white paper is available for download […]
March 31, 2021
Rare Perspectives: Factor X Deficiency
Keys To Clinical Trial Success In Rare Disease Indications This Atlantic Research Group rare disease case study is available for […]
March 31, 2020
Patient Centricity in a Consumer Model
White Paper This Atlantic Research Group rare disease white paper is available for download as a PDF. Video Killed the […]
March 31, 2019